Long-Term Recall of Amyloid PET Results
Scanlan, M.; Hiegert, H.; Townley, R. A.; Almahgraby, A.; Key, M. N.; Morris, J. K.; Burns, J. M.; Vidoni, E. D.
Show abstract
We assessed long-term recall and perceived impact of amyloid PET results among 92 cognitively normal adults who received structured result disclosure 6-9 years earlier. Two-thirds correctly recalled their result; only three misremembered the result as the opposite of what was communicated. Participants reported limited behavior change, though those with elevated scans more often endorsed lifestyle modifications. Perceived AD risk aligned with scan status but did not appear to cause lasting psychological distress. Most participants, regardless of result, viewed the experience positively and would undergo testing again. These findings support the long-term acceptability of disclosing amyloid PET results.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Evaluation of a speech-based AI system for early detection of Alzheimer’s disease remotely via smartphones 93%
- Association of Item-Level Responses to Cognitive Function Index with Tau Pathology and Hippocampal volume in The A4 Study 93%
- Brain Amyloid and the Transition to Dementia in Down Syndrome 92%
Similar papers in this journal
- Continuous Associations Between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer’s Disease 94%
- Use of Lecanemab and Donanemab in the Canadian Healthcare System: Evidence, Challenges, and Areas for Future Research 93%
- Real-world datasets for the International Registry for Alzheimer’s Disease and Other Dementias (InRAD) and other registries: an international consensus 91%
Similar papers in this journal
- A Qualitative Study of People with Alzheimer’s Disease in a Memory Clinic Considering Lecanemab Treatment 94%
- Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study 92%
- Association between motor task acquisition and hippocampal atrophy across cognitively unimpaired, amnestic Mild Cognitive Impairment, and Alzheimer’s disease individuals 91%
Similar papers in this journal
- Development and validation of a harmonized memory score for multicenter Alzheimer's disease and related dementia research 92%
- Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study 92%
- Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort 92%